THE efficacy of the Oxford/AstraZeneca vaccine in children as young as six is set to be tested in a new clinical trial.
Researchers will use 300 volunteers to assess whether the jag – known as the the ChAdOx1 nCoV-19 vaccine – will produce a strong immune response in children aged between six and 17.
The Oxford jag is one of three to have been approved for use in adults in the UK, along with those from Pfizer/BioNTech and Moderna.
READ MORE: Long Covid could account for up to 20% of coronavirus cases, immunologist says
Andrew Pollard, professor of paediatric infection and immunity, and chief investigator on the Oxford vaccine trial, said: “While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.
“These new trials will extend our understanding of control of SARS-CoV2 to younger age groups.”
The first vaccinations under the trial will take place this month, with up to 240 children receiving the vaccine and the others receiving a control meningitis jag.
Earlier this week, England’s deputy chief medical officer said “several” trials were under way to develop vaccines that are safe and effective in children.
Professor Jonathan Van-Tam told ITV News: “It is perfectly possible that we will have some licensed children’s vaccines for Covid-19 by the end of the year.”
The Royal College of Paediatrics and Child Health has said there is evidence Covid-19 can cause death and severe illness in children, but that this is rare.
It said: “In children, the evidence is now clear that Covid-19 is associated with a considerably lower burden of morbidity and mortality compared to that seen in the elderly.
“There is also some evidence that children may be less likely to acquire the infection. The role of children in transmission, once they have acquired the infection, is unclear, although there is no clear evidence that they are any more infectious than adults.”
READ MORE: Covid Scotland: Places with most coronavirus cases this week
The University of Oxford said theirs was the first trial in the 6-17 age group. It said other trials had begun but only measuring efficacy in those aged 16 and 17.
Rinn Song, paediatrician and clinician-scientist at the Oxford Vaccine Group, said: “The Covid-19 pandemic has had a profound negative impact on the education, social development and emotional well-being of children and adolescents, beyond illness and rare severe disease presentations.
“It is therefore important to collect data on the safety and the immune response to our coronavirus vaccine in these age groups, so that they could potentially benefit from inclusion in vaccination programs in the near future.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereLast Updated:
Report this comment Cancel